Track the Neurotech International Limited share price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Neurotech International Limited has published 4 reports. Market capitalisation: €21m. The latest transaction was disclosed on 8 September 2026 (Other). Among the most active insiders: Andrew Chapman Date of appointment 8 September 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Neurotech International Limited 是一家专注于开发基于技术治疗神经系统疾病解决方案的公司。该公司在 XASX 市场上市。